←
Wiley Clinical and Health6,992 posts
Wiley Clinical and Health avatar

Wiley Clinical and Health

@WileyHealth

Find the latest research in oncology and hematology, clinical health, and medical research and applied clinical practice. Unleash your next big discovery.

◷ Joined December 2012▧ 3,181 Photos and videos
Wiley Clinical and Health avatar
Wiley Clinical and Health@WileyHealth·Nov 17

How well are #CancerClinicalTrial participants reimbursed for non-medical expenses? A new @JournalCancer study found trial-related travel, lodging, and caregiving costs varied by income, distance, and trial phase. HealthDay covers the data: bit.ly/4iM0Oar @smakhnoon

Wiley Clinical and Health avatar
Wiley Clinical and Health@WileyHealth·Nov 17

What defines early #melanoma? 🔬 Explore the latest research on borderline lesions, overdiagnosis and emerging diagnostics in this special issue of the International Journal of Dermatology. Read here : bit.ly/4feo12J

0:55
Wiley Clinical and Health avatar
Wiley Clinical and Health@WileyHealth·Nov 16

Can vaginal gel support short-term high-risk HPV clearance? New randomized trial findings show silicon dioxide-based gel didn't improve loss of detectable cervical hrHPV DNA after 3 months compared with observation. 🔗 Read the research: bit.ly/4zC0NvE @AOGS_tweets

HemaSphere Journal (IF = 11.4) avatar
⟳ Wiley Clinical and Health retweeted
HemaSphere Journal (IF = 11.4)@Hemasphere_EHA·Nov 12

🚨The abstract submission deadline for EHA's Research Conference is coming up soon: November 20. We'd love to see your work featured so please consider submitting! #ReCon2027

Last chance to submit your abstract for round one of the fifth EHA Research Conference (#ReCon2027)! Taking place March 22–25, 2027, in St. Paul’s Bay, Malta, EHA ReCon 2027 will bring together basic and translational researchers to explore the latest breakthroughs in RNA biology and its rapidly expanding therapeutic applications in hematology. Designed as an interactive and collaborative forum, the conference is an opportunity to share your research and connect with colleagues from across the field. Whether you are at the beginning of your scientific journey or an established researcher, EHA ReCon 2027 offers an ideal environment to learn from pioneers in RNA therapeutics and gain fresh perspectives. Present your work and start conversations that could lead to your next research collaboration or career opportunity. The first round of abstract submission closes November 20, 2026 (23:59 CET). Submit in this round to be considered for an oral presentation. Abstracts submitted in round two will be considered for poster presentation only. Don’t miss your chance to submit: eha.fyi/ReCon2027_abstracts

0:10